Paul R. J. Davey

机构：AstraZeneca (United Kingdom), AstraZeneca (Singapore) · ORCID：0000-0001-7269-2526

发表论文 71 篇 · 总被引 906 次 · h-index 13

代表论文

Bicyclic β‐Sheet Mimetics that Target the Transcriptional Coactivator β‐Catenin and Inhibit Wnt Signaling (2021 · Angewandte Chemie International Edition · 被引 64)
Discovery of a Potent and Selective ATAD2 Bromodomain Inhibitor with Antiproliferative Activity in Breast Cancer Models (2022 · Journal of Medicinal Chemistry · 被引 38)
Antisense oligonucleotide activity in tumour cells is influenced by intracellular LBPA distribution and extracellular vesicle recycling (2021 · Communications Biology · 被引 23)
Addition of Fluorine and a Late-Stage Functionalization (LSF) of the Oral SERD AZD9833 (2020 · ACS Medicinal Chemistry Letters · 被引 21)
Discovery of a Potent and Orally Bioavailable Zwitterionic Series of Selective Estrogen Receptor Degrader-Antagonists (2023 · Journal of Medicinal Chemistry · 被引 17)
Access to 2-Oxabicyclo[2.1.1]hexanes and their use in Scaffold Hopping (2024 · Organic Letters · 被引 13)